MOLECULES TO MEDICINES LTD - LONDON
| Company Profile | Company Filings |
Overview
MOLECULES TO MEDICINES LTD is a Private Limited Company from LONDON ENGLAND and has the status: Active.
MOLECULES TO MEDICINES LTD was incorporated 4 years ago on 04/09/2019 and has the registered number: 12189862. The accounts status is MICRO ENTITY and accounts are next due on 30/06/2024.
MOLECULES TO MEDICINES LTD was incorporated 4 years ago on 04/09/2019 and has the registered number: 12189862. The accounts status is MICRO ENTITY and accounts are next due on 30/06/2024.
MOLECULES TO MEDICINES LTD - LONDON
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
74909 - Other professional, scientific and technical activities n.e.c.
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 30 / 9 | 30/09/2022 | 30/06/2024 |
Registered Office
33 ST. GEORGES ROAD
LONDON
N13 4AT
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 03/09/2023 | 17/09/2024 |
Map
ENGLAND
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| NEIL MILLER | Jun 1970 | British | Director | 2019-09-04 | CURRENT |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Dr Neil Derek Miller | 2019-09-04 | 6/1970 | Hitchin |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| ACCOUNTS - Final Accounts preparation | 2024-05-25 | 30-09-2023 | 93,391 equity |
| ACCOUNTS - Final Accounts preparation | 2023-05-24 | 30-09-2022 | 95,930 equity |
| ACCOUNTS - Final Accounts preparation | 2022-05-14 | 30-09-2021 | 78,748 equity |
| ACCOUNTS - Final Accounts preparation | 2021-05-27 | 30-09-2020 | 40,987 equity |